KRAS and pancreatic neoplasm: The pharmacological dosage of FGF21 supplementation effectively inhibited pancreatic intraepithelial neoplasia lesions, inhibited liver metastasis, and prolonged the overall survival of KRAS-mediated pancreatic cancer under the high-fat-diet challenge.